BioSense
PrivateLast Round
Grant
Sep 30, 2020
Company Overview
BioSense is a medical technology company that develops non-contact ECG monitoring solutions for constant, non-invasive patient monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioSense Comparables
Compare BioSense with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Electrocept | 94% | |
| Capical GmbH | 81% | |
| SensVita, Inc. | 81% |
BioSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 30, 2020 | ||||
| Accelerator | Jun 26, 2020 |
Key People
Founding team and executive leadership
BioSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| Alliance for Pediatric Device Innovation | Grant |
| Food and Drug Administration | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 76% MoM.
- Sep 30, 2020
Received grant from Alliance for Pediatric Device Innovation and FDA.
BioSense Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access